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Certain clinical and morphologic findings are described in 11 
patients with hypertrophic cardiomyopathy complicated by infec-
tive endocarditis that produced severe mitral or aortic valve 
regurgitation, or both, necessitating valve replacement. All 11 
patients had changes in the operatively excised valve or valves 
characteristic of healed infective endocarditis. The infection in-
volved only the mitral valve in seven patients, only the aortic valve 
in three patients and both valves in one patient. 
Study of the operatively excised mitral valves indicated that the 
healed vegetations were located most commonly on the left ven-
tricular aspects of the anterior mitral leaflet, indicating that 
vegetation had formed at contact points of this leaflet with mural 
From 1961 through October 1989, 626 patients with hyper-
trophic cardiomyopathy underwent a cardiac operation at 
the Surgery Branch of the National Heart, Lung, and Blood 
Institute: partial septotomy/septectomy alone in 539 patients 
(86%); septotomy/septectomy followed later by mitral valve 
replacement in 19 patients (3%) and mitral valve replacement 
alone in 68 patients (11%). Of the 87 patients undergoing 
mitral valve replacement with or without septotomy/ 
septectomy, mitral valve replacement was performed be-
cause of severe left ventricular outflow obstruction unasso-
ciated with severe thickening of the ventricular septum in 65 
patients; damage to either the mitral or aortic valve at the 
time of earlier septotomy/septectomy in 5 patients; inability 
to wean the patient from cardiopulmonary bypass after 
septotomy/septectomy in 3 patients; severe regurgitation of 
uncertain etiology in 3 patients; and valvular regurgitation 
caused by or worsened by infective endocarditis in 11 
patients. This report describes certain clinical and morpho-
logic cardiac findings in the 11 patients with hypertrophic 
cardiomyopathy with severe mitral or aortic valvular regur-
gitation, or both, from infective endocarditis. 
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endocardium of the left ventricular outflow tract. In all 11 
patients, the infective endocarditis either worsened preexisting 
valve regurgitation or initiated valve regurgitation and led to 
worsened signs and symptoms of cardiac dysfunction, necessitat-
ing valve replacement. Functional class improved in the nine 
patients who survived 7 to 101 months after valve replacement. 
Hypertrophic cardiomyopathy appears to be a factor predis-
posing to infective endocarditis. Patients with hypertrophic car-
diomyopathy should receive prophylactic antibiotic therapy dur-
ing procedures that predispose to infective endocarditis. 
(JAm Coil Cardio/1992;19:365-71) 
Methods 
Clinical characteristics (Tables 1 to 3). All11 patients had 
clear clinical evidence of hypertrophic cardiomyopathy: 
1) each had evidence of left ventricular hypertrophy on both 
the electrocardiogram (ECG) and the M-mode echocardio-
gram; 2) immediately before cardiac valve replacement, only 
I patient had a dilated left ventricular cavity as determined 
by left ventricular angiography and the dilation was of mild 
degree; 3) none had a history of systemic hypertension and, 
with one exception, all had systemic arterial indirect pres-
sure recordings :s:I40 mm Hg systolic and :s:90 mm Hg 
diastolic (Patient 3 had a systemic arterial direct pressure of 
160/90 mm Hg recorded immediately before valve replace-
ment, but other pressures recorded were normal); 4) al-
though cardiac index was normal in only four of nine patients 
in whom it was recorded, the other five had evidence of 
severe valvular regurgitation (worsened by infective en-
docarditis) at the time of the recording; 5) the maximal 
thickness of the ventricular septum was greater than that of 
the left ventricular free wall in all patients before either valve 
replacement or partial ventricular septotomy/septectomy; 
and 6) all patients had hemodynamic documentation of 
subaortic obstruction at some time. 
Characteristics of infective endocarditis. All 11 patients 
had evidence of active infective endocarditis at some time 
(Fig. 1 to 7). Ten patients had a typical clinical illness of 
active infective endocarditis. Of the nine patients with one 
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clinical episode of active infective endocarditis, the interval 
between active infective endocarditis and valve replacement 
ranged from 3 to 204 months (mean 54, median 17). This 
interval was <1 year in four patients. Patient 11 (Table 1) 
had two episodes of active infective endocarditis that oc-
curred 168 and 27 months, respectively, before valve re-
placement (Fig. 7). Only the second episode caused clinical 
worsening of this patient's cardiac status. Patient 4 appar-
ently never had a clinical illness diagnosed as active infective 
endocarditis, but examination of the operatively excised 
mitral valve disclosed a large deficit in the anterior mitral 
leaflet adjacent to several ruptured chordae tendineae, ana-
tomic findings diagnostic of healed infective endocarditis (1 ). 
Of the 11 patients, 9 had active infective endocarditis before 
they were admitted to the National Institutes of Health; 1 
had active infective endocarditis treated at another hospital, 
but hypertrophic cardiomyopathy had previously been diag-
nosed at the National Institutes of Health; and 1 patient had 
active infective endocarditis while hospitalized at the Na-
tional Institutes of Health. Diagnosis of hypertrophic cardio-
myopathy had been established previously in 7 of the 10 
patients with a clinical illness diagnosed as active infective 
endocarditis; it was made in the other 3 patients after active 
infective endocarditis had healed. In five patients, a factor 
other than hypertrophic cardiomyopathy predisposing to 
infective endocarditis was apparent: dental procedures in 
Patients 4 and 5, cardiac catheterization in Patients 6 and 10 
and opiate addiction in Patient 11. 
During active infective endocarditis, information regard-
ing the results of blood cultures were known in eight 
patients: in two, the blood cultures were negative and in six 
a bacterium was identified (alpha streptococcus in Patients 7, 
10 and 11; group D streptococcus in two patients [nonen-
terococcal in Patient 2 and enterococcus in Patient 6]; and 
Cardiobacterium hominis in Patient 4). All 11 patients, 
however, had anatomic deficiencies of mitral or aortic valve 
cusps, and in those with infective endocarditis involving the 
mitral valve, there were associated ruptured chordae ten-
dineae. The 10 patients with clear clinical evidence of active 
infective endocarditis received appropriate antibiotic treat-
ment, and by the time of valve replacement, the infection 
had healed in all 10 patients. The M-mode echocardiogram 
immediately before valve replacement showed "echo densi-
ties" compatible with healed vegetations in four of seven 
patients in whom healed infective endocarditis involved the 
mitral valve and two of four in whom it involved the aortic 
valve. 
Valvular regurgitation caused by infective endocarditis. 
Active infective endocarditis worsened the symptomatic 
status in nine patients by at least one New York Heart 
Association functional class. It also increased the intensity 
of the precordial systolic murmur (mitral regurgitation) in 
three of three patients in whom this information was known 
and caused the appearance of a basal diastolic murmur in all 
four patients with aortic regurgitation. Despite the appear-
ance or worsening of valvular regurgitation, the left ventric-
Table 2. M-Mode Echocardiographic Data Before and After Operation in the 11 Patients With Infective Endocarditis Complicating 
Hypertrophic Cardiomyopathy and Requiring Valve Replacement 
Pt 
No. 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Interval 
Echo to VR 
(days) 
9(MVR) 
PO 
78 (MVR) 
PO 
12(MVR) 
PO 
65 (MVR) 
PO 
16(MVR) 
PO 
33 (MVR) 
PO 
8(AVR) 
PO 
37 (AYR) 
POt 
41 (AYR) 
PO 
10 (MVR, A VR) 
PO 
Wall Thickness (mm) 
VSd LVd 
20 
16 
17 
19 
15 
32 
14 
26 
20 
10 
26 
24 
11 
13 
10 
14 
15 
-· 
14 
13 
13 
10 
14 
11 
13 
11 
Cavity (mm) 
LVd LVs LA 
41 
37 
36 
40 
-· 
46 
56 
40 
-· 
44 
51 
53 
-· 
18 
18 
16 
18 
-· 
28 
38 
22 
-· 
22 
29 
41 
-· 
45 
35 
56 
40 
57 
55 
57 
68 
72 
63 
43 
40 
49 
45 
60 
52 
54 
FS 
(%) 
56 
51 
55 
55 
39 
32 
45 
50 
43 
23 
Echo Density 
MV AV 
+ 
0 
0 
± 
+ 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
+ 
+ 
0 
0 
Flail 
MV AV 
+ 
+ 
0 
0 
0 
± 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
+ 
0 
0 
SAM 
+ 
+ 
+ 
+ 
0 
0 
0 
0 
0 
0 
*Paradoxical movement; tventricular septal defect created at operation. AV = aortic valve; AYR = aortic valve replacement; d = end-diastole; Echo = 
echocardiography; FS =fractional shortening; LA= left atrium; LV= left ventricle; MV =mitral valve; MVR =mitral valve replacement; PO= after operation; 
s = peak systole; SAM = systolic anterior motion of the anterior mitral leaflet; VS = ventricular septum; - = not applicable; other abbreviations as in Table I. 
Table 3. Hemodynamic and Angiographic Data Immediately Before and 2:6 Months After Valve Replacement in 11 Patients With 
Infective Endocarditis Complicating Hypertrophic Cardiomyopathy 
Pt 
No. 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Time ofCath 
(mo PO) 
Pre-VR 
PO (6) 
Pre-VR 
Pre-VR 
PO (6) 
Pre-VR 
Pre-VRt 
PO (JO)t 
PO (21) 
Pre-VR 
PO (6) 
Pre-VR 
Pre-VR 
Pre-VR 
PO (12) 
Pre-VR 
PO (8) 
PO (58) 
Pre-VR 
PO (76) 
PA* 
(s/d) 
66/40 
32114 
80/40 
88/40 
44/20 
90/40 
50/25 
60/25 
45/23 
50/25 
85/35 
50/25 
24/11 
60/30 
30112 
55/30 
75/35 
RV* 
(s/d) 
65/16 
32/4 
80/18 
88/14 
44/6 
90/10 
50/10 
120/30 
60/9 
45/8 
24/5 
50/5 
85/12 
50115 
24/7 
65115 
30/5 
5516 
75/16 
RA* 
(m) 
7 
4 
18 
11 
4 
8 
5 
19 
11 
4 
3 
6 
6 
4 
9 
6 
5 
15 
Mean 
PAW* 
26 
9 
45 
32 
14 
30 
15 
35 
24 
20 
31 
38 
27 
6 
20 
16 
12 
17 
31 
LA* 
a v 
36 38 
16 10 
AF 50 
32 44 
16 12 
27 40 
23 55 
32 
28 36 
AF 50 
AF 55 
40 45 
13 8 
10 22 
20 28 
26 20 
28 44 
LV* 
(s/d) 
180/25 
130/12 
138/24 
140/30 
150/14 
165/32 
245/40 
130/24 
110110 
105/6 
120/20 
120/14 
164/34 
115/16 
200/28 
105/20 
240/30 
150/24 
SA* 
(s/d) 
118/60 
125/65 
138/60 
114/65 
158/88 
120/70 
160/90 
130/65 
105/70 
105/60 
130/75 
120/60 
86/40 
110/65 
130/68 
105/55 
120/70 
100/30 
145/85 
LV-SA 
psg* 
62 
5 
0 
26 
0 
45 
85 
0 
5 
0 
0 
0 
78 
5 
70 
0 
140 
5 
MRby 
LV Cine 
(0-4+) 
4+ 
4+ 
4+ 
0 
3+ 
3+ 
2+ 
3+ 
0 
4+ 
4+ 
I+ 
I+ 
3+ 
3+ 
AR by CAD 
AA Cine by 
(0-4+) Cine 
I+ 
0 
0 
0 
3+ 
2+ 
3+ 
I+ 
0 
0 
0 
0 
0 
0 
Cl 
3.8 
2.1 
2.1 
1.8 
3.3 
2.0 
3.7 
2.0 
2.5 
2.5 
2.3 
1.5 
2.0 
3.1 
4.4 
1.7 
2.1 
*Pressures in mm Hg. tCardiac catheterization (Cath) 36 months before valve replacement; *peribasilar bioprosthetic communication found by left ventricular 
cineangiography (Cine) and it was operatively closed after this cardiac catheterization procedure. §This patient was the only one . with significant coronary 
narrowing and he had aortocoronary bypass grafting in addition to valve replacement (VR). a = a wave; AA = ascending aorta; AF = atrial fibrillation; AR = 
aortic regurgitation; CAD= coronary artery narrowing >50% in diameter of> I major artery; Cl = cardiac index in liters/min per m2 ; LA = left atrium; LV = 
left ventricle; MR =mitral regurgitation; PA =pulmonary artery; PAW= pulmonary artery wedge; PO= after operation (months); Pre =before; psg =peak 
systolic gradient; Pt = patient; RA = right atrium; RV = right ventricle; SA = systemic artery; s/d = peak systole/end-diastole; v = v wave. 
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Figure 1 (above). Patient l. Operatively excised mitral valve. 
a, Leaflets, chordae tendineae and attached papillary muscles show-
ing loss of tissue in the posterior leaflet and absence of chordae 
tendineae (arrows). A large deposit of calcium is present and is 
better seen in b, a radiograph of the excised valve. c, M-mode 
echocardiogram taken shortly before mitral valve replacement, 
showing thickening and impaired mobility of the anterior mitral 
leaflet and fluttering (arrows) of the posterior leaflet. ECG = 
electrocardiogram; RV = right ventricular cavity; VS = ventricular 
septum. 
Figure 2 (below). Patient 2. Operatively excised mitral valve (a, b, 
and c) and M-mode echocardiogram (d). a, Radiograph of the 
opened valve. The arrows point to a calcific deposit. b and 
c, Close-up views of the atrial aspect of a portion of both leaflets. The 
anterior leaflet contains two perforations (solid arrows) and the poste-
rior leaflet one perforation (dashed arrow). d, Typical echocardiogram 
in hypertrophic cardiomyopathy with asymmetric thickening of the 
anterior ventricular septum (VS). The arrows point to dense echoes of 
the thickened anterior mitral leaflet, which contacts the ventricular 
septum in diastole. Mild mitral systolic anterior motion is present (*). 
PW = posterior wall; RV = right ventricular cavity. 
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Figure 3. Patient 3. Opened mitral valve. a, Atrial surface. 
b Ventricular surface. The arrows designate the area where chordae t~ndineae are missing (ruptured) and a site where a portion of ~he 
leaflet is absent (destroyed by the previous infection). A = antenor 
mitral leaflet. 
ular cavity was of normal size on the echocardiogram 
immediately before valve replacement in nine of nine pa-
tients; left ventricular angiograms in the other two patients 
disclosed mild left ventricular cavity dilation in one of them. 
The degree of valvular regurgitation immediately before 
valve replacement in each of the 11 patients was severe: in 
the 7 patients with isolated mitral valve replacement, the 
degree of mitral regurgitation by left ventricular angiography 
was either 3+/4+ or 4+/4+; in the 3 patients with isolated 
aortic valve replacement, the degree of aortic regurgitation 
by aortic root angiography was 3+/4+ in 2 and 2+/4+ in 1; 
in the single patient with replacement of both left-sided 
cardiac valves, the degree of mitral regurgitation was 4+/4+ 
and aortic regurgitation, 1 +/4+. 
Effect of infective endocarditis on the left ventricular 
outflow pressure gradient. Active infective endocarditis in-
volving the mitral valve was associated with a decrease in 
Figure 4. Patient 5. Op~ned mitral. valve fro~ its atrial aspe~t, 
showing a large perforation (arrow) m the an~enor leaflet (A) w~th 
adjacent focal calcific deposits. The perforation represents a stte 
where vegetation had been present. 
Figure 5. Patient 6. Opened mitral ~alve from i~s atrial aspect, 
showing a large indentation (arrow) m the postenor leaflet.. Both 
anterior (A) and posterior leaflets are thickened by fibrous tissue. 
The indentation represents a site of previous vegetation. 
the peak systolic pressure gradient between the left ventricle 
and a systemic artery. In the three patients who had cardiac 
catheterization before and after active infective endocardi-
tis, the peak systolic pressure gradient decreased from 90 to 
62 mm Hg in Patient 1, from 100 to 5 mm Hg in Patient 4 and 
from 76 to 55 mm Hg in Patient 6. 
Results of cardiac valve replacements. Valve replacement 
was successful in nine patients. The other two patients 
(Patients 7 and 11), each of whom died within 30 days of 
valve replacement, were the only patients who had had 
partial septectomy and septotomy before cardiac valve re-
placement. Of the nine hospital survivors after valve re-
placement (combined with partial septotomy and septec-
tomy in four), eight were in functional class I or 11 and one 
was in class Ill when seen 6 to 21 months after valve 
replacement, whereas preoperatively three had been. in 
functional class Ill and five in functional class IV. Card1ac 
catheterization was performed 6 to 21 months (mean 14) 
after valve replacement in seven of the nine long-term 
survivors (Table 3). In three of the seven patients, no left 
ventricular outflow tract obstruction was present preopera-
tively and the postoperative study disclosed no pressure 
gradient between the left ventricle and a systemic artery 
during peak systole. In the other four patients, the peak 
systolic pressure gradient before valve replacement (com-
bined with partial septotomy and septectomy in three pa-
tients) decreased from an average of 74 mm Hg (range 62 to 
85) preoperatively to ::;5 mm Hg postoperatively. 
Discussion 
Major findings of present study. Although · 30 reports 
describing one or more patients (19 were single case studies) 
with hypertrophic cardiomyopathy and infective endocardi-
tis have appeared (cases tabulated by Alessandri et al. [2]), 
the presence of infective endocarditis was confirmed an~­
tomically (2-11) only in 15 of the reported 56 cases and m 
none was the type of valvular damage illustrated. The 
present study analyzed 11 patients from the same center with 
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Figure 6. Patient 7. a, Unopened mitral valve. b, Opened mitral 
valve showing its atrial aspect. The arrow points to an indentation at 
the junction of the anterior (A) and posterior leaflets. Several 
chordae tendineae are missing (ruptured) at this site. c, Radiograph 
of the opened mitral valve. Several calcific deposits are present in 
the annular region of the posterior leaflet. 
hypertrophic cardiomyopathy complicated by infective en-
docarditis necessitating replacement of one or more cardiac 
valves in each, and in each the operatively excised valve was 
studied. It is apparent that infective endocarditis should be 
recognized as a complication of hypertrophic cardiomyopa-
thy and that the latter predisposes to infective endocarditis. 
The frequency with which the complication occurs is un-
clear. The present study suggests that among patients with 
hypertrophic cardiomyopathy with mitral or aortic valve 
regurgitation, or both, severe enough to warrant valve 
replacement, infective endocarditis often is responsible for 
the severe regurgitation. Of the 87 patients with hyper-
trophic cardiomyopathy who underwent valve replacement 
at our institution, ll underwent this procedure because of 
damage by infective endocarditis. None of the other opera-
tively excised valves had cusp perforations or tears or 
ruptured chordae tendineae and therefore it is unlikely that 
any of these other patients had had infective endocarditis at 
any time. 
Location of the vegetations in infective endocarditis com-
plicating hypertrophic cardiomyopathy. The most frequent 
site of vegetations in patients with hypertrophic cardiomy-
opathy is the mitral valve and specifically its anterior leaflet. 
It is this leaflet, of course, which tends to contact the mural 
endocardium of the ventricular septum during one or both 
phases of the cardiac cycle and it is likely that vegetations 
form at these contact sites. Of our ll patients, 8 had 
vegetations that left telltale residua of infective endocarditis 
on the mitral valve (l also had damage to the aortic valve, 
but the damage was not diagnostic of healed infective 
endocarditis [l]) and 3 had both clinical and anatomic 
evidence of damage to one or more aortic valve cusps by 
infective endocarditis. The vegetations on the anterior mitral 
leaflet appear to have been on their ventricular aspects, 
unlike those in most patients with active infective endocardi-
tis involving the mitral valve. The mechanism of formation 
of aortic valve vegetations in patients with hypertrophic 
cardiomyopathy is unclear. In three of our four patients 
having aortic valve replacement, the left ventricular aortic 
Figure 7. Patient 8. Three-cusped aortic valve with severe destruc-
tion of one of the three cusps by the infective process. 
ROBERTS ET AL. 371 JACC Vol. 19, No. 2 
February 1992:365-71 INFECTIVE ENDOCARDITIS IN HYPERTROPHIC CARDIOMYOPATHY 
peak systolic pressure gradient was high (70, 78 and 
140 mm Hg, respectively), whereas only one of the seven 
patients with isolated mitral valve replacement had a left 
ventricular outflow pressure gradient of this magnitude. The 
vegetations on the aortic valve appear to have been located 
on the ventricular aspects of these cusps, the usual location 
of vegetations on this valve. 
Valvular regurgitation after infective endocarditis in hy-
pertrophic cardiomyopathy. The present study shows that 
infective endocarditis complicating hypertrophic cardiomy-
opathy can result in serious consequences. In allll patients, 
the symptomatic status was unequivocally worsened by active 
infective endocarditis that healed. Additionally, the intensity of 
the precordial systolic murmur increased in the patients with 
infective endocarditis involving the mitral valve, and infective 
endocarditis involving the aortic valve caused the appearance 
of a murmur of aortic regurgitation, which was confirmed in 
each by angiography. The degree of valvular regurgitation was 
severe in allll patients; however, despite the severe degree of 
regurgitation, the left ventricular cavity immediately before 
valve replacement was not dilated in any patient on M-mode 
echocardiography and was only mildly dilated in one of two 
patients studied by angiography. 
Benefit of valve replacement. Despite recognized poten-
tial complications of mitral valve replacement in patients 
with hypertrophic cardiomyopathy (12), the present study 
indicates that valve replacement for infective endocarditis 
complicating hypertrophic cardiomyopathy may result in a 
striking diminution or disappearance of previous symptoms 
of cardiac dysfunction. 
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